1Collins Rm Arrnitage J, Parish S, et al. Heart Protection Study of cholesterollowering with simvastatin in 5963 people with diabetes: a randomized placebo - controlled trial. Lancet 2003; 361:2005 -2016.
2Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterollowering foods vs lovastatin on serum lipids and C - reactive protein. JAMA 2003;290:502-510.
3Harold E, Editor. Therapy for Diabetes Mellitus and Related Disorders. Forth Edition 2004; 33: 293 - 209.
4Rubin HB, Robin SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high- density lipoprotein cholesterol. Veterans Affairs High - Density lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410- 418.
5Stamler J, O Vaccaro, JD Neaton, et al. Diabetes, other risk factors, and 12 - yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434- 444.
6Miller M, Seidler A, Kwiterovich PO, et al. Long term predicators of subsequent cardio vascular events with coronary artery disease and "Desirable" levels of plasma total cholerterol. Circulation 1992;86:1165.
7Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non- insulin dependent diabetes mellitus( UKPDS:23) :BMJ 1998;316:823-828.
8Howard BV, Robbins DC, Sievers ML, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the Strong heart Study. Arterioscler Thromb Vasc Biol 2000;20:830- 835.
9Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lowvastatin in men and women with average cholesterol levels; results of AFCAPS/TexCAPS. JAMA 1998; 279:1615 - 1622.
10Pyorala K, Pederson TR, Kjekshus J et al. For the Scandinavian Simvastatin Survival Study: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study(4S).Diabetes Care 1997 ;20: 614 - 620.
